
Herbert Goldstein
Examiner (ID: 18423)
| Most Active Art Unit | 2608 |
| Art Unit(s) | 2607, 2403, 2616, 2613, 2214, 2605, 2611, 2608 |
| Total Applications | 1485 |
| Issued Applications | 1358 |
| Pending Applications | 2 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14280431
[patent_doc_number] => 20190137500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Salivary Transcriptomic and Microbial Biomarkers for Pancreatic Cancer
[patent_app_type] => utility
[patent_app_number] => 16/191481
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191481 | Salivary Transcriptomic and Microbial Biomarkers for Pancreatic Cancer | Nov 14, 2018 | Abandoned |
Array
(
[id] => 16236791
[patent_doc_number] => 20200254025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => METHODS OF TREATING AN ISCHEMIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/758457
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758457 | Methods of treating an ischemic disease | Oct 23, 2018 | Issued |
Array
(
[id] => 14185791
[patent_doc_number] => 20190112600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/157183
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157183 | CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF | Oct 10, 2018 | Abandoned |
Array
(
[id] => 14185791
[patent_doc_number] => 20190112600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/157183
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157183 | CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF | Oct 10, 2018 | Abandoned |
Array
(
[id] => 18013524
[patent_doc_number] => 11505808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Engineered nucleic acid-targeting nucleic acids
[patent_app_type] => utility
[patent_app_number] => 16/152337
[patent_app_country] => US
[patent_app_date] => 2018-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 80
[patent_no_of_words] => 60086
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/152337 | Engineered nucleic acid-targeting nucleic acids | Oct 3, 2018 | Issued |
Array
(
[id] => 17104647
[patent_doc_number] => 11124847
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-09-21
[patent_title] => Systems and methods for assessing perturbations in cellular differentiation using reporter cell lines
[patent_app_type] => utility
[patent_app_number] => 16/151204
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5601
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/151204 | Systems and methods for assessing perturbations in cellular differentiation using reporter cell lines | Oct 2, 2018 | Issued |
Array
(
[id] => 16956266
[patent_doc_number] => 11060110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Adeno-associated virus vectors for treatment of glycogen storage disease
[patent_app_type] => utility
[patent_app_number] => 16/148435
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 15928
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148435 | Adeno-associated virus vectors for treatment of glycogen storage disease | Sep 30, 2018 | Issued |
Array
(
[id] => 19090978
[patent_doc_number] => 11952408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => HPV-specific binding molecules
[patent_app_type] => utility
[patent_app_number] => 16/652379
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 99
[patent_no_of_words] => 170009
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652379 | HPV-specific binding molecules | Sep 27, 2018 | Issued |
Array
(
[id] => 13987209
[patent_doc_number] => 20190062762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency
[patent_app_type] => utility
[patent_app_number] => 16/143520
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143520 | Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency | Sep 26, 2018 | Abandoned |
Array
(
[id] => 15634913
[patent_doc_number] => 10590435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
[patent_app_type] => utility
[patent_app_number] => 16/142921
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20570
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142921
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142921 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Sep 25, 2018 | Issued |
Array
(
[id] => 13982533
[patent_doc_number] => 20190060424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Sumoylation of Serca2A and Cardiovascular Disease
[patent_app_type] => utility
[patent_app_number] => 16/121273
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121273 | Sumoylation of Serca2A and Cardiovascular Disease | Sep 3, 2018 | Abandoned |
Array
(
[id] => 13987203
[patent_doc_number] => 20190062759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => GENERATION OF ACYL AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/119910
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119910 | GENERATION OF ACYL AMINO ACIDS | Aug 30, 2018 | Abandoned |
Array
(
[id] => 16475071
[patent_doc_number] => 10849991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Gene therapy for the treatment of a disease of retinal cone cells
[patent_app_type] => utility
[patent_app_number] => 16/109627
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7586
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109627 | Gene therapy for the treatment of a disease of retinal cone cells | Aug 21, 2018 | Issued |
Array
(
[id] => 17768248
[patent_doc_number] => 11400167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Gene therapy for the treatment of a retinal degeneration disease
[patent_app_type] => utility
[patent_app_number] => 16/109630
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5979
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109630 | Gene therapy for the treatment of a retinal degeneration disease | Aug 21, 2018 | Issued |
Array
(
[id] => 16459557
[patent_doc_number] => 10842885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Factor IX encoding nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/105583
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 33
[patent_no_of_words] => 36633
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/105583 | Factor IX encoding nucleotides | Aug 19, 2018 | Issued |
Array
(
[id] => 14031673
[patent_doc_number] => 10227576
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-03-12
[patent_title] => Engineered cascade components and cascade complexes
[patent_app_type] => utility
[patent_app_number] => 16/104875
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 74
[patent_no_of_words] => 51066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104875 | Engineered cascade components and cascade complexes | Aug 16, 2018 | Issued |
Array
(
[id] => 19638175
[patent_doc_number] => 12168776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Nucleic acid molecules and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/636583
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 68498
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636583 | Nucleic acid molecules and uses thereof | Aug 8, 2018 | Issued |
Array
(
[id] => 17784909
[patent_doc_number] => 11408022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Preparation method of anti-oxidation polypeptide
[patent_app_type] => utility
[patent_app_number] => 16/968501
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 2846
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968501 | Preparation method of anti-oxidation polypeptide | Jul 18, 2018 | Issued |
Array
(
[id] => 13827141
[patent_doc_number] => 20190017055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => REAL-TIME REPORTER SYSTEMS FOR MONITORING BASE EDITING
[patent_app_type] => utility
[patent_app_number] => 16/035286
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035286 | Real-time reporter systems for monitoring base editing | Jul 12, 2018 | Issued |
Array
(
[id] => 13479739
[patent_doc_number] => 20180291412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => Expression of Mammalian Proteins in Pseudomonas Fluorescens
[patent_app_type] => utility
[patent_app_number] => 16/014348
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014348 | Expression of Mammalian Proteins in Pseudomonas Fluorescens | Jun 20, 2018 | Abandoned |